Next‐generation biomarkers for alcohol consumption and alcohol use disorder diagnosis, prognosis, and treatment: A critical review
Alcohol, Clinical and Experimental Research · 2025-01 · 49 (1) · 5-24
DOI: 10.1111/acer.15476 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Alcohol, Clinical and Experimental Research, online erschienen am 12.11.2024. Verfasst von Shaunna L Clark und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry and Behavioral Sciences, Texas A&M University, College Station, Texas, USA. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 121 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAAA NIH HHS, NCATS NIH HHS, NIA NIH HHS.
Themen: Sucht und Abhängigkeit
Abstract (Originalsprache)
This critical review summarizes the current state of omics‐based biomarkers in the alcohol research field. We first provide definitions and background information on alcohol and alcohol use disorder (AUD), biomarkers, and “omic” technologies. We next summarize using (1) genetic information as risk/prognostic biomarkers for the onset of alcohol‐related problems and the progression from regular drinking to problematic drinking (including AUD), (2) epigenetic information as diagnostic biomarkers for AUD and risk biomarkers for alcohol consumption, (3) transcriptomic information as diagnostic biomarkers for AUD, risk biomarkers for alcohol consumption, and (4) metabolomic information as diagnostic biomarkers for AUD, risk biomarkers for alcohol consumption, and predictive biomarkers for response to acamprosate in subjects with AUD. In the final section, the clinical implications of the findings are discussed, and recommendations are made for future research.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Psychiatry and Behavioral Sciences, Texas A&M University, College Station, Texas, USA.
- Mental Illness Research, Education and Clinical Center, Crescenz Veterans Affairs Medical Center, Philadelphia, Pennsylvania, USA.
- Department of Psychiatry, Center for Studies of Addiction, Perelman School of Medicine of the University of Pennsylvania, Philadelphia, Pennsylvania, USA.
- Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic College of Medicine and Science, Rochester, Minnesota, USA.
- Department of Psychiatry and Psychology, Mayo Clinic College of Medicine and Science, Rochester, Minnesota, USA.
- Neuroscience Program, Mayo Clinic College of Medicine and Science, Rochester, Minnesota, USA.
ORCID-Profile: Shaunna L Clark, Emily E Hartwell, Doo-Sup Choi, John H Krystal, Robert O Messing, Laura B Ferguson
Förderung
- NIAAA NIH HHS
- NCATS NIH HHS
- NIA NIH HHS
- U.S. Department of Defense
- VISN 4 Mental Illness Research, Education, and Clinical Center
- NICHD NIH HHS
- CSRD VA
- National Institute of Child Health and Human Development
Zitieren
APA
Clark, S. L., Hartwell, E. E., Choi, D. S., Krystal, J. H., Messing, R. O., & Ferguson, L. B. (2025). Next‐generation biomarkers for alcohol consumption and alcohol use disorder diagnosis, prognosis, and treatment: A critical review. Alcohol, Clinical and Experimental Research, 49(1), 5-24. https://doi.org/10.1111/acer.15476
Vancouver
Clark SL, Hartwell EE, Choi DS, Krystal JH, Messing RO, Ferguson LB. Next‐generation biomarkers for alcohol consumption and alcohol use disorder diagnosis, prognosis, and treatment: A critical review. Alcohol, Clinical and Experimental Research. 2025;49(1):5-24. doi:10.1111/acer.15476
BibTeX
@article{Clark2025,
author = {Clark, Shaunna L and Hartwell, Emily E and Choi, Doo-Sup and Krystal, John H and Messing, Robert O and Ferguson, Laura B},
title = {Next‐generation biomarkers for alcohol consumption and alcohol use disorder diagnosis, prognosis, and treatment: A critical review},
journal = {Alcohol, Clinical and Experimental Research},
year = {2025},
volume = {49},
number = {1},
pages = {5--24},
doi = {10.1111/acer.15476}
}
EUVIMED